Comparison of abdominal and arm areas in patients receiving subcutaneous heparin in terms of development of pain, hematoma, and ecchymosis

Basit Öğe Kaydı
dc.authoridCENGİZ, ZELİHA/0000-0002-3819-1717
dc.authoridUCUZAL, MERAL/0000-0003-3930-3490
dc.authorwosidCENGİZ, ZELİHA/ABI-4480-2020
dc.authorwosidUCUZAL, MERAL/B-1556-2018
dc.contributor.authorCengiz, Zeliha
dc.contributor.authorOzkan, Meral
dc.date.accessioned2024-08-04T20:44:37Z
dc.date.available2024-08-04T20:44:37Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe purpose of this study was to compare the abdominal and arm areas in the patients using subcutaneous heparin in terms of pain, hematoma, and ecchymosis development. As a result of subcutaneous heparin injections, complications such as pain, ecchymosis, and hematoma may develop in the injection site. The injection site chosen for injection is one of the factors that are effective on complications. This quasi-experimental study was conducted with 54 patients at orthopedicstraumatology and cardiothoracic surgery clinics of a university hospital. The data were collected using a patient description and follow-up form, visual analog scale, transparent film, and a chronometer. Ecchymosis and hematoma were evaluated at the 48th hour after injection, whereas the pain level was evaluated right after the injection, and the pain duration was evaluated during the injection. The rate of pain in the arm area was statistically higher. Differences between the areas in terms of level and duration of pain and development and size of ecchymosis and hematoma were not significant. More pain developed due to heparin injection in the arm area than in the abdominal area. No differences were observed between the areas in terms of level and duration of pain, development and size of ecchymosis, or development and size of hematoma.en_US
dc.identifier.doi10.1016/j.jvn.2018.06.003
dc.identifier.endpage215en_US
dc.identifier.issn1062-0303
dc.identifier.issn1532-6578
dc.identifier.issue4en_US
dc.identifier.pmid30458944en_US
dc.identifier.scopus2-s2.0-85049516055en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage208en_US
dc.identifier.urihttps://doi.org/10.1016/j.jvn.2018.06.003
dc.identifier.urihttps://hdl.handle.net/11616/98370
dc.identifier.volume36en_US
dc.identifier.wosWOS:000450370900009en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofJournal of Vascular Nursingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMolecular-Weight Heparinen_US
dc.subjectInjection Durationen_US
dc.subjectClinical-Evaluationen_US
dc.subjectSiteen_US
dc.subjectColden_US
dc.titleComparison of abdominal and arm areas in patients receiving subcutaneous heparin in terms of development of pain, hematoma, and ecchymosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu